AI-generated price forecast for MRNA across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of July 2026: K3vl4r's AI model currently reads MRNA as 3/4 bearish across its horizons (1 of 4 timeframes pointing up), with a last price of 80.44. See our public, auditable track record →
Last price
80.44
AI outlook
3/4 bearish
Timeframes up
1 / 4
| Horizon | Direction | Projected move (end of horizon) | Bullish prob. |
|---|---|---|---|
| 1-hour~4 weeks out | ▼ Down | -24.56% | — |
| 4-hour~3 months out | ▼ Down | -67.31% | — |
| Daily~6 months out | ▼ Down | -64.89% | — |
| Weekly~2 years out | ▲ Up | +66.27% | — |
From the market-news feed the forecasts are read against.
🔒
See the full MRNA forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's AI model currently reads MRNA as 3/4 bearish — 1 of 4 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects MRNA toward $79.60 over the next ~4 weeks, a -0.2% move from $79.80. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Over its longest horizon (~~2 years), the model's projected target for MRNA is $80.29 (+0.7% vs $79.76). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Biotech & Pharma forecasts — browse the full sector.
Or see the full MRNA price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.